Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 3 |
2010 | 1 |
2013 | 2 |
2014 | 1 |
2015 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Optimization of peptide hydroxamate inhibitors of insulin-degrading enzyme reveals marked substrate-selectivity.
J Med Chem. 2013 Mar 28;56(6):2246-55. doi: 10.1021/jm301280p. Epub 2013 Mar 15.
J Med Chem. 2013.
PMID: 23437776
Free PMC article.
Small-molecule activators of insulin-degrading enzyme discovered through high-throughput compound screening.
Cabrol C, Huzarska MA, Dinolfo C, Rodriguez MC, Reinstatler L, Ni J, Yeh LA, Cuny GD, Stein RL, Selkoe DJ, Leissring MA.
Cabrol C, et al.
PLoS One. 2009;4(4):e5274. doi: 10.1371/journal.pone.0005274. Epub 2009 Apr 22.
PLoS One. 2009.
PMID: 19384407
Free PMC article.
Item in Clipboard
Insulin-degrading enzyme is exported via an unconventional protein secretion pathway.
Zhao J, Li L, Leissring MA.
Zhao J, et al.
Mol Neurodegener. 2009 Jan 14;4:4. doi: 10.1186/1750-1326-4-4.
Mol Neurodegener. 2009.
PMID: 19144176
Free PMC article.
Item in Clipboard
Selective Targeting of Extracellular Insulin-Degrading Enzyme by Quasi-Irreversible Thiol-Modifying Inhibitors.
Abdul-Hay SO, Bannister TD, Wang H, Cameron MD, Caulfield TR, Masson A, Bertrand J, Howard EA, McGuire MP, Crisafulli U, Rosenberry TR, Topper CL, Thompson CR, Schürer SC, Madoux F, Hodder P, Leissring MA.
Abdul-Hay SO, et al.
ACS Chem Biol. 2015 Dec 18;10(12):2716-24. doi: 10.1021/acschembio.5b00334. Epub 2015 Sep 30.
ACS Chem Biol. 2015.
PMID: 26398879
Free PMC article.
Item in Clipboard
Development of monoclonal antibodies and quantitative ELISAs targeting insulin-degrading enzyme.
Delledonne A, Kouri N, Reinstatler L, Sahara T, Li L, Zhao J, Dickson DW, Ertekin-Taner N, Leissring MA.
Delledonne A, et al.
Mol Neurodegener. 2009 Oct 16;4:39. doi: 10.1186/1750-1326-4-39.
Mol Neurodegener. 2009.
PMID: 19835587
Free PMC article.
Item in Clipboard
Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin.
Leissring MA, Malito E, Hedouin S, Reinstatler L, Sahara T, Abdul-Hay SO, Choudhry S, Maharvi GM, Fauq AH, Huzarska M, May PS, Choi S, Logan TP, Turk BE, Cantley LC, Manolopoulou M, Tang WJ, Stein RL, Cuny GD, Selkoe DJ.
Leissring MA, et al.
PLoS One. 2010 May 7;5(5):e10504. doi: 10.1371/journal.pone.0010504.
PLoS One. 2010.
PMID: 20498699
Free PMC article.
Item in Clipboard
The blood glucose-lowering effect of racecadotril is not attributable to inhibition of insulin-degrading enzyme.
Kurklinsky S, Abdul-Hay SO, McGuire MP, Howard EA, Knight J, Leissring MA.
Kurklinsky S, et al.
Horm Metab Res. 2014 Jan;46(1):73-4. doi: 10.1055/s-0033-1353211. Epub 2013 Aug 23.
Horm Metab Res. 2014.
PMID: 23975847
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite